European and US regulators approve AbbVie's new combo for all hepatitis C genotypes
Glecaprevir/pibrentasvir is effective for people with HIV/HCV co-infection
Hepatitis C treatment is effective and feasible in Africa
Curing hepatitis C improves diabetes control
New pangenotypic hepatitis C drug combinations recommended for approval in the European Union
Experts question Cochrane review of hepatitis C treatment
Indonesian buyers club helps people obtain generic hepatitis C treatment
Hepatitis C virus reinfection is uncommon after being cured with DAAs
